Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 238 results found. Search for [ Wockhardt ]

Results 1 to 21 of 238
www.businesstoday.in
February 1, 2018



BusinessToday.in
January 8, 2018
While the Sensex hit an all-time high of 34,356, Nifty was trading above 10,600 for the first time ever, rising more than 50 points from Friday's close. Of 50 Nifty stocks, 45 were in trading the green.


E Kumar Sharma
New Delhi, December 28, 2017
 The just concluded year, hurt Indian pharma companies in more ways than one


BusinessToday.in
October 30, 2017
Energy firms gained on higher crude prices as sentiment was upbeat in domestic and global energy stocks with Brent crude hitting its highest level since July 2015 after Saudi Arabia agreed to support the extension of a global oil production cut agreement. While Reliance Industries gained over 1 percent, the ONGC stock rose up to 4 per cent post its Q2 earnings.


PB Jayakumar
New Delhi, August 31, 2017
The company which started its Indian operations in 2004 is going to launch some of its latest epilepsy and cancer drugs in India.


PB Jayakumar
Delhi, June 24, 2017
A number of Indian companies are facing action from the USFDA for failing manufacturing quality standards.


Prosenjit Datta
Delhi, May 1, 2017
The post-Independence Indian pharma industry was really created by a generation of scientist-entrepreneurs who took advantage of the two changes made by the government in the 1970s.


PB Jayakumar
Delhi, May 1, 2017
Unlike many of the India Inc. successors who had got smoothly running companies on a platter, Habil Khorakiwala's younger son Murtaza faced a tough beginning.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


BusinessToday.in
New York, March 21, 2017
India is home to world's fourth highest number of billionaires with Reliance Industries chief Mukesh Ambani leading the club of more than 100 super rich Indians, according to a new list released by Forbes magazine.


Team BT
Delhi, March 7, 2017
Warren Buffett talking about Ajit Jain, widely believed to be a strong contender to succeed the billionaire investor at Berkshire Hathaway, in his annual letter to shareholders.


PTI
New Delhi, March 2, 2017
Intra-day, it tumbled 6.67 per cent to Rs 701. On NSE, shares of the company dipped 4.84 per cent to close at Rs 713.65.


Reuters
February 6, 2017
The Reserve Bank of India is expected to cut interest rates by 25 basis points at its policy review on Wednesday, a Reuters poll showed, after consumer inflation hit a two-year low in December, giving the central bank room to ease.


PB Jayakumar
Delhi, December 12, 2016
Torrent Pharmaceuticals was a late entrant to the US, but Samir Mehta has led it to fast-paced growth in that market.


PB Jayakumar
Delhi, November 26, 2016
Many global healthcare chains and investors are pumping money into hospitals in India. This may prove to be a game changer for the country's healthcare sector.


Joe C Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


PTI
September 25, 2016
From Ambanis and Adanis to Premjis and Khorakiwalas, several generation-next leaders of India's leading family-run businesses have joined crorepati club when it comes to their salaries and other perks.


BusinessToday.in
August 16, 2016
Among losers, the Infosys stock fell as much as 3.25 per cent, Wockhardt and Jet Airways too closed lower on their Q1 earnings.


PTI
August 13, 2016
Drug firm Wockhardt on Saturday reported a fall of 82.65 per cent in consolidated net profit to Rs 15.89 crore for the first quarter ended June 30, mainly on account of dip in sales and increased expenditure.


BusinessToday.in
New Delhi, August 8, 2016
The import alert has been issued under 'Import Alert 66-40', which authorises the health regulator \"detention without physical examination of drugs from firms which have not met drug GMPs\".


PAGES 1 OF 12  12345